Venetoclax Basket Trial for High Risk Hematologic Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew E Place, MD, PhD
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California San Francisco-Benioff Children'S Hospital
San Francisco, California, United States
Recruiting - Children'S Hospital Colorado
Aurora, Colorado, United States
Recruiting - Children'S Healthcare of Atlanta at Arthur M. Blank Hospital
Atlanta, Georgia, United States
Recruiting - Ann & Robert H Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
Recruiting - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Andrew E Place, MD, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Mar 2023
- Primary completion
- 2 Jul 2028
- Completion
- 2 Jul 2030
- Last update posted
- 12 Mar 2026
- Registered enrollment
- 30
- Registry id
- NCT05292664
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.